ID   GLRX5_HUMAN             Reviewed;         157 AA.
AC   Q86SX6; Q0X088; Q3YML0; Q86WY3; Q8IZ54;
DT   01-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-2005, sequence version 2.
DT   18-JUN-2025, entry version 173.
DE   RecName: Full=Glutaredoxin-related protein 5, mitochondrial;
DE   AltName: Full=Monothiol glutaredoxin-5;
DE   Flags: Precursor;
GN   Name=GLRX5; Synonyms=C14orf87;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT THR-146.
RX   PubMed=16110529; DOI=10.1038/nature03887;
RG   The Tuebingen 2000 screen consortium;
RA   Wingert R.A., Galloway J.L., Barut B., Foott H., Fraenkel P., Axe J.L.,
RA   Weber G.J., Dooley K., Davidson A.J., Schmid B., Paw B.H., Shaw G.C.,
RA   Kingsley P., Palis J., Schubert H., Chen O., Kaplan J., Zon L.I.;
RT   "Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for
RT   vertebrate haem synthesis.";
RL   Nature 436:1035-1039(2005).
RN   [2]
RP   ERRATUM OF PUBMED:16110529.
RG   The Tuebingen 2000 screen consortium;
RA   Wingert R.A., Galloway J.L., Barut B., Foott H., Fraenkel P., Axe J.L.,
RA   Weber G.J., Dooley K., Davidson A.J., Schmid B., Paw B.H., Shaw G.C.,
RA   Kingsley P., Palis J., Schubert H., Chen O., Kaplan J.;
RL   Nature 437:920-920(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Kurosawa N., Isobe M., Saito M.;
RT   "Biological function of human glutaredoxin 3 (Grx 3), a novel mitochondrial
RT   monothiol Grx.";
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=B-cell;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-146.
RC   TISSUE=Skin, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INVOLVEMENT IN SIDBA3.
RX   PubMed=17485548; DOI=10.1182/blood-2007-02-072520;
RA   Camaschella C., Campanella A., De Falco L., Boschetto L., Merlini R.,
RA   Silvestri L., Levi S., Iolascon A.;
RT   "The human counterpart of zebrafish shiraz shows sideroblastic-like
RT   microcytic anemia and iron overload.";
RL   Blood 110:1353-1358(2007).
RN   [8]
RP   INVOLVEMENT IN SIDBA3, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=20364084; DOI=10.1172/jci40372;
RA   Ye H., Jeong S.Y., Ghosh M.C., Kovtunovych G., Silvestri L., Ortillo D.,
RA   Uchida N., Tisdale J., Camaschella C., Rouault T.A.;
RT   "Glutaredoxin 5 deficiency causes sideroblastic anemia by specifically
RT   impairing heme biosynthesis and depleting cytosolic iron in human
RT   erythroblasts.";
RL   J. Clin. Invest. 120:1749-1761(2010).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   FUNCTION.
RX   PubMed=23615440; DOI=10.1091/mbc.e12-09-0644;
RA   Uzarska M.A., Dutkiewicz R., Freibert S.A., Lill R., Muehlenhoff U.;
RT   "The mitochondrial Hsp70 chaperone Ssq1 facilitates Fe/S cluster transfer
RT   from Isu1 to Grx5 by complex formation.";
RL   Mol. Biol. Cell 24:1830-1841(2013).
RN   [11]
RP   FUNCTION, INVOLVEMENT IN SPAHGC, VARIANT SPAHGC LYS-51 DEL, AND
RP   CHARACTERIZATION OF VARIANT SPAHGC LYS-51 DEL.
RX   PubMed=24334290; DOI=10.1093/brain/awt328;
RA   Baker P.R. II, Friederich M.W., Swanson M.A., Shaikh T., Bhattacharya K.,
RA   Scharer G.H., Aicher J., Creadon-Swindell G., Geiger E., MacLean K.N.,
RA   Lee W.T., Deshpande C., Freckmann M.L., Shih L.Y., Wasserstein M.,
RA   Rasmussen M.B., Lund A.M., Procopis P., Cameron J.M., Robinson B.H.,
RA   Brown G.K., Brown R.M., Compton A.G., Dieckmann C.L., Collard R.,
RA   Coughlin C.R. II, Spector E., Wempe M.F., Van Hove J.L.;
RT   "Variant non ketotic hyperglycinemia is caused by mutations in LIAS, BOLA3
RT   and the novel gene GLRX5.";
RL   Brain 137:366-379(2014).
RN   [12]
RP   CLEAVAGE OF TRANSIT PEPTIDE [LARGE SCALE ANALYSIS] AFTER ALA-31, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [13]
RP   INTERACTION WITH BOLA1.
RX   PubMed=27532773; DOI=10.7554/elife.15991;
RA   Melber A., Na U., Vashisht A., Weiler B.D., Lill R., Wohlschlegel J.A.,
RA   Winge D.R.;
RT   "Role of Nfu1 and Bol3 in iron-sulfur cluster transfer to mitochondrial
RT   clients.";
RL   Elife 5:0-0(2016).
RN   [14]
RP   INTERACTION WITH BOLA1.
RX   PubMed=27532772; DOI=10.7554/elife.16673;
RA   Uzarska M.A., Nasta V., Weiler B.D., Spantgar F., Ciofi-Baffoni S.,
RA   Saviello M.R., Gonnelli L., Muehlenhoff U., Banci L., Lill R.;
RT   "Mitochondrial Bol1 and Bol3 function as assembly factors for specific
RT   iron-sulfur proteins.";
RL   Elife 5:0-0(2016).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 35-150 IN COMPLEX WITH GLUTATHIONE
RP   AND IRON-SULFUR CLUSTER, AND SUBUNIT.
RX   PubMed=21029046; DOI=10.1042/bj20101286;
RA   Johansson C., Roos A.K., Montano S.J., Sengupta R., Filippakopoulos P.,
RA   Guo K., von Delft F., Holmgren A., Oppermann U., Kavanagh K.L.;
RT   "The crystal structure of human GLRX5: iron-sulfur cluster co-ordination,
RT   tetrameric assembly and monomer activity.";
RL   Biochem. J. 433:303-311(2011).
RN   [16]
RP   VARIANTS SIDBA3 GLN-101 AND SER-148.
RX   PubMed=25342667; DOI=10.1182/blood-2014-08-598508;
RA   Liu G., Guo S., Anderson G.J., Camaschella C., Han B., Nie G.;
RT   "Heterozygous missense mutations in the GLRX5 gene cause sideroblastic
RT   anemia in a Chinese patient.";
RL   Blood 124:2750-2751(2014).
RN   [17]
RP   CHARACTERIZATION OF VARIANTS SIDBA3 GLN-101 AND SER-148, AND INTERACTION
RP   WITH ISCU.
RX   PubMed=26100117; DOI=10.1002/jcb.25267;
RA   Liu G., Wang Y., Anderson G.J., Camaschella C., Chang Y., Nie G.;
RT   "Functional analysis of GLRX5 mutants reveals distinct functionalities of
RT   GLRX5 protein.";
RL   J. Cell. Biochem. 117:207-217(2016).
CC   -!- FUNCTION: Monothiol glutaredoxin involved in mitochondrial iron-sulfur
CC       (Fe/S) cluster transfer (PubMed:20364084, PubMed:23615440). Receives
CC       2Fe/2S clusters from scaffold protein ISCU and mediates their transfer
CC       to apoproteins, to the 4Fe/FS cluster biosynthesis machinery, or export
CC       from mitochondrion (PubMed:20364084, PubMed:23615440, PubMed:24334290).
CC       Required for normal regulation of hemoglobin synthesis by the iron-
CC       sulfur protein ACO1 (PubMed:20364084). {ECO:0000269|PubMed:20364084,
CC       ECO:0000269|PubMed:23615440, ECO:0000269|PubMed:24334290}.
CC   -!- SUBUNIT: Homodimer (PubMed:21029046). Interacts with ISCU
CC       (PubMed:26100117). Interacts with BOLA1 (PubMed:27532772,
CC       PubMed:27532773). {ECO:0000269|PubMed:26100117,
CC       ECO:0000269|PubMed:27532772, ECO:0000269|PubMed:27532773,
CC       ECO:0000305|PubMed:21029046}.
CC   -!- INTERACTION:
CC       Q86SX6; Q53S33: BOLA3; NbExp=13; IntAct=EBI-1049910, EBI-12086950;
CC       Q86SX6; Q8IWL3: HSCB; NbExp=3; IntAct=EBI-1049910, EBI-1805738;
CC       PRO_0000141650; Q9Y3E2: BOLA1; NbExp=6; IntAct=EBI-27823755, EBI-1049556;
CC       PRO_0000141650; Q53S33: BOLA3; NbExp=5; IntAct=EBI-27823755, EBI-12086950;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix
CC       {ECO:0000269|PubMed:20364084}.
CC   -!- DISEASE: Anemia, sideroblastic, 3, pyridoxine-refractory (SIDBA3)
CC       [MIM:616860]: A form of sideroblastic anemia, a bone marrow disorder
CC       defined by the presence of pathologic iron deposits in erythroblast
CC       mitochondria. Sideroblastic anemia is characterized by anemia of
CC       varying severity, hypochromic peripheral erythrocytes, systemic iron
CC       overload secondary to chronic ineffective erythropoiesis, and the
CC       presence of bone marrow ringed sideroblasts. Sideroblasts are
CC       characterized by iron-loaded mitochondria clustered around the nucleus.
CC       SIDBA3 is refractory to treatment with vitamin B6, while iron chelation
CC       therapy may result in clinical improvement. SIDBA3 inheritance is
CC       autosomal recessive. {ECO:0000269|PubMed:17485548,
CC       ECO:0000269|PubMed:20364084, ECO:0000269|PubMed:25342667,
CC       ECO:0000269|PubMed:26100117}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Spasticity, childhood-onset, with hyperglycinemia (SPAHGC)
CC       [MIM:616859]: An autosomal recessive disorder characterized by
CC       childhood-onset of spasticity, spinal lesions, leukodystrophy, optic
CC       atrophy in some patients, non-ketotic hyperglycinemia, and defective
CC       enzymatic glycine cleavage. Glycine levels in the cerebrospinal fluid
CC       are mildly increased in some but not all patients. The increase is less
CC       pronounced than in patients with classic non-ketotic hyperglycinemia.
CC       {ECO:0000269|PubMed:24334290}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the glutaredoxin family. Monothiol subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAD62364.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ083331; AAZ30731.1; -; mRNA.
DR   EMBL; BX248075; CAD62364.1; ALT_INIT; mRNA.
DR   EMBL; AB223038; BAF02301.1; -; mRNA.
DR   EMBL; CH471061; EAW81607.1; -; Genomic_DNA.
DR   EMBL; BC023528; AAH23528.2; -; mRNA.
DR   EMBL; BC047680; AAH47680.1; -; mRNA.
DR   CCDS; CCDS9936.1; -.
DR   RefSeq; NP_057501.2; NM_016417.2.
DR   PDB; 2MMZ; NMR; -; A=35-150.
DR   PDB; 2WUL; X-ray; 2.40 A; A/B/C/D=35-150.
DR   PDBsum; 2MMZ; -.
DR   PDBsum; 2WUL; -.
DR   AlphaFoldDB; Q86SX6; -.
DR   BMRB; Q86SX6; -.
DR   SMR; Q86SX6; -.
DR   BioGRID; 119386; 82.
DR   ComplexPortal; CPX-6862; Mitochondrial BOLA1-GLRX5 iron-sulfur cluster assembly complex.
DR   ComplexPortal; CPX-6863; Mitochondrial BOLA3-GLRX5 iron-sulfur cluster assembly complex.
DR   DIP; DIP-50654N; -.
DR   FunCoup; Q86SX6; 1784.
DR   IntAct; Q86SX6; 18.
DR   MINT; Q86SX6; -.
DR   STRING; 9606.ENSP00000328570; -.
DR   GlyGen; Q86SX6; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q86SX6; -.
DR   PhosphoSitePlus; Q86SX6; -.
DR   SwissPalm; Q86SX6; -.
DR   BioMuta; GLRX5; -.
DR   DMDM; 83288163; -.
DR   jPOST; Q86SX6; -.
DR   MassIVE; Q86SX6; -.
DR   PaxDb; 9606-ENSP00000328570; -.
DR   PeptideAtlas; Q86SX6; -.
DR   ProteomicsDB; 69646; -.
DR   Pumba; Q86SX6; -.
DR   TopDownProteomics; Q86SX6; -.
DR   Antibodypedia; 47425; 139 antibodies from 24 providers.
DR   DNASU; 51218; -.
DR   Ensembl; ENST00000331334.5; ENSP00000328570.4; ENSG00000182512.5.
DR   GeneID; 51218; -.
DR   KEGG; hsa:51218; -.
DR   MANE-Select; ENST00000331334.5; ENSP00000328570.4; NM_016417.3; NP_057501.2.
DR   UCSC; uc001yem.2; human.
DR   AGR; HGNC:20134; -.
DR   CTD; 51218; -.
DR   DisGeNET; 51218; -.
DR   GeneCards; GLRX5; -.
DR   HGNC; HGNC:20134; GLRX5.
DR   HPA; ENSG00000182512; Tissue enhanced (skeletal).
DR   MalaCards; GLRX5; -.
DR   MIM; 609588; gene.
DR   MIM; 616859; phenotype.
DR   MIM; 616860; phenotype.
DR   OpenTargets; ENSG00000182512; -.
DR   Orphanet; 255132; Adult-onset autosomal recessive sideroblastic anemia.
DR   Orphanet; 401866; Childhood-onset spasticity with hyperglycinemia.
DR   VEuPathDB; HostDB:ENSG00000182512; -.
DR   eggNOG; KOG0911; Eukaryota.
DR   GeneTree; ENSGT00550000075082; -.
DR   HOGENOM; CLU_026126_2_0_1; -.
DR   InParanoid; Q86SX6; -.
DR   OMA; TKLMPQC; -.
DR   OrthoDB; 415696at2759; -.
DR   PAN-GO; Q86SX6; 1 GO annotation based on evolutionary models.
DR   PhylomeDB; Q86SX6; -.
DR   PathwayCommons; Q86SX6; -.
DR   Reactome; R-HSA-1362409; Mitochondrial iron-sulfur cluster biogenesis.
DR   SignaLink; Q86SX6; -.
DR   BioGRID-ORCS; 51218; 371 hits in 1161 CRISPR screens.
DR   EvolutionaryTrace; Q86SX6; -.
DR   GeneWiki; GLRX5; -.
DR   GenomeRNAi; 51218; -.
DR   Pharos; Q86SX6; Tbio.
DR   PRO; PR:Q86SX6; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; Q86SX6; protein.
DR   Bgee; ENSG00000182512; Expressed in trabecular bone tissue and 206 other cell types or tissues.
DR   ExpressionAtlas; Q86SX6; baseline and differential.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:1990229; C:iron-sulfur cluster assembly complex; IPI:ComplexPortal.
DR   GO; GO:0005759; C:mitochondrial matrix; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0051537; F:2 iron, 2 sulfur cluster binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0044571; P:[2Fe-2S] cluster assembly; IGI:UniProtKB.
DR   GO; GO:0045454; P:cell redox homeostasis; NAS:ComplexPortal.
DR   GO; GO:0030097; P:hemopoiesis; ISS:UniProtKB.
DR   GO; GO:0006879; P:intracellular iron ion homeostasis; NAS:ComplexPortal.
DR   GO; GO:0016226; P:iron-sulfur cluster assembly; NAS:ComplexPortal.
DR   GO; GO:0051604; P:protein maturation; IGI:UniProtKB.
DR   CDD; cd03028; GRX_PICOT_like; 1.
DR   FunFam; 3.40.30.10:FF:000005; Glutaredoxin 5; 1.
DR   Gene3D; 3.40.30.10; Glutaredoxin; 1.
DR   InterPro; IPR002109; Glutaredoxin.
DR   InterPro; IPR033658; GRX_PICOT-like.
DR   InterPro; IPR004480; Monothiol_GRX-rel.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   NCBIfam; TIGR00365; Grx4 family monothiol glutaredoxin; 1.
DR   PANTHER; PTHR10293; GLUTAREDOXIN FAMILY MEMBER; 1.
DR   PANTHER; PTHR10293:SF16; GLUTAREDOXIN-RELATED PROTEIN 5, MITOCHONDRIAL; 1.
DR   Pfam; PF00462; Glutaredoxin; 1.
DR   SUPFAM; SSF52833; Thioredoxin-like; 1.
DR   PROSITE; PS51354; GLUTAREDOXIN_2; 1.
DR   neXtProt; NX_Q86SX6; -.
DR   PharmGKB; PA134992547; -.
DR   TreeFam; TF318988; -.
PE   1: Evidence at protein level;
KW   2Fe-2S; 3D-structure; Disease variant; Iron; Iron-sulfur; Metal-binding;
KW   Mitochondrion; Phosphoprotein; Proteomics identification;
KW   Redox-active center; Reference proteome; Transit peptide.
FT   TRANSIT         1..31
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255, ECO:0007744|PubMed:25944712"
FT   CHAIN           32..157
FT                   /note="Glutaredoxin-related protein 5, mitochondrial"
FT                   /id="PRO_0000141650"
FT   DOMAIN          42..145
FT                   /note="Glutaredoxin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00686"
FT   BINDING         59
FT                   /ligand="glutathione"
FT                   /ligand_id="ChEBI:CHEBI:57925"
FT                   /evidence="ECO:0000269|PubMed:21029046"
FT   BINDING         67
FT                   /ligand="[2Fe-2S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:190135"
FT                   /ligand_note="ligand shared between dimeric partners"
FT                   /evidence="ECO:0000269|PubMed:21029046"
FT   BINDING         97..101
FT                   /ligand="glutathione"
FT                   /ligand_id="ChEBI:CHEBI:57925"
FT                   /evidence="ECO:0000269|PubMed:21029046"
FT   BINDING         109
FT                   /ligand="glutathione"
FT                   /ligand_id="ChEBI:CHEBI:57925"
FT                   /evidence="ECO:0000269|PubMed:21029046"
FT   BINDING         122..123
FT                   /ligand="glutathione"
FT                   /ligand_id="ChEBI:CHEBI:57925"
FT                   /evidence="ECO:0000269|PubMed:21029046"
FT   MOD_RES         59
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80Y14"
FT   MOD_RES         156
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80Y14"
FT   VARIANT         51
FT                   /note="Missing (in SPAHGC; no effect on protein abundance
FT                   in patient cells; probably reduced activity in iron-sulfur
FT                   cluster assembly that results in reduced production of the
FT                   lipoate cofactor and protein lipoylation;
FT                   dbSNP:rs869320757)"
FT                   /evidence="ECO:0000269|PubMed:24334290, ECO:0000305"
FT                   /id="VAR_076672"
FT   VARIANT         101
FT                   /note="K -> Q (in SIDBA3; deficiency in Fe-S cluster
FT                   synthesis; does not impair ISCU binding;
FT                   dbSNP:rs869312752)"
FT                   /evidence="ECO:0000269|PubMed:25342667,
FT                   ECO:0000269|PubMed:26100117"
FT                   /id="VAR_074550"
FT   VARIANT         146
FT                   /note="A -> T (in dbSNP:rs11628901)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:16110529"
FT                   /id="VAR_026125"
FT   VARIANT         148
FT                   /note="L -> S (in SIDBA3; deficiency in Fe-S cluster
FT                   synthesis; does not impair ISCU binding;
FT                   dbSNP:rs765487627)"
FT                   /evidence="ECO:0000269|PubMed:25342667,
FT                   ECO:0000269|PubMed:26100117"
FT                   /id="VAR_074551"
FT   HELIX           42..51
FT                   /evidence="ECO:0007829|PDB:2WUL"
FT   STRAND          52..60
FT                   /evidence="ECO:0007829|PDB:2WUL"
FT   STRAND          62..67
FT                   /evidence="ECO:0007829|PDB:2WUL"
FT   HELIX           68..79
FT                   /evidence="ECO:0007829|PDB:2WUL"
FT   STRAND          86..89
FT                   /evidence="ECO:0007829|PDB:2WUL"
FT   HELIX           94..104
FT                   /evidence="ECO:0007829|PDB:2WUL"
FT   STRAND          111..114
FT                   /evidence="ECO:0007829|PDB:2WUL"
FT   STRAND          117..120
FT                   /evidence="ECO:0007829|PDB:2WUL"
FT   HELIX           122..131
FT                   /evidence="ECO:0007829|PDB:2WUL"
FT   HELIX           133..140
FT                   /evidence="ECO:0007829|PDB:2WUL"
FT   TURN            146..148
FT                   /evidence="ECO:0007829|PDB:2WUL"
SQ   SEQUENCE   157 AA;  16628 MW;  5E6873BD5DE91F86 CRC64;
     MSGSLGRAAA ALLRWGRGAG GGGLWGPGVR AAGSGAGGGG SAEQLDALVK KDKVVVFLKG
     TPEQPQCGFS NAVVQILRLH GVRDYAAYNV LDDPELRQGI KDYSNWPTIP QVYLNGEFVG
     GCDILLQMHQ NGDLVEELKK LGIHSALLDE KKDQDSK
//
